Evidence map›Paper›PMID 31425526›Full record

ArticlePloS one2019

Political priority and pathways to scale-up of childhood cancer care in five nations.

Avram E Denburg, Adriana Ramirez, Suresh Pavuluri, Erin McCann, Shivani Shah, Tricia Alcasabas, Federico Antillon, Ramandeep Arora, Soad Fuentes-Alabi, Lorna Renner and 6 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap.Journal of the National Cancer Institute · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Avram E DenburgDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.ORCID 0000-0003-0039-0742
Adriana RamirezHarvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America.ORCID 0000-0002-4975-5645
Suresh PavuluriHarvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Erin McCannHarvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America.ORCID 0000-0001-6312-1916
Shivani ShahChild Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Tricia AlcasabasPhilippine General Hospital, Manila, Philippines.ORCID 0000-0002-3452-0245
Federico AntillonSchool of Medicine, Universidad Franciso Marroquin, Guatemala City, Guatemala.
Ramandeep AroraMax Super Specialty Hospital, New Delhi, India.ORCID 0000-0002-2613-4539
Soad Fuentes-AlabiHospital Nacional de Niños Benjamin Bloom, San Salvador, El Salvador.ORCID 0000-0003-4245-3537
Lorna RennerKorle Bu Teaching Hospital, Accra, Ghana.
Catherine LamDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.ORCID 0000-0003-1363-5331
Paola FriedrichDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.ORCID 0000-0002-5265-3113
Brandon MaserChild Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Lisa ForceDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.ORCID 0000-0003-3014-9204
Carlos Rodriguez GalindoDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.ORCID 0000-0002-2360-8946
Rifat AtunHarvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America.ORCID 0000-0002-1531-5983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite increasing global attention to non-communicable diseases (NCDs) and their incorporation into universal health coverage (UHC), the factors that determine whether and how NCDs are prioritized in national health agendas and integrated into health systems remain poorly understood. Childhood cancer is a leading non-communicable cause of death in children aged 0-14 years worldwide. We investigated the political, social, and economic factors that influence health system priority-setting on childhood cancer care in a range of low- and middle-income countries (LMIC). METHODS AND

findingsBased on in-depth qualitative case studies, we analyzed the determinants of priority-setting for childhood cancer care in El Salvador, Guatemala, Ghana, India, and the Philippines using a conceptual framework that considers four principal influences on political prioritization: political contexts, actor power, ideas, and issue characteristics. Data for the analysis derived from in-depth interviews (n = 68) with key informants involved in or impacted by childhood cancer policies and programs in participating countries, supplemented by published academic literature and available policy documents. Political priority for childhood cancer varies widely across the countries studied and is most influenced by political context and actor power dynamics. Ghana has placed relatively little national priority on childhood cancer, largely due to competing priorities and a lack of cohesion among stakeholders. In both El Salvador and Guatemala, actor power has played a central role in generating national priority for childhood cancer, where well-organized and -resourced civil society organizations have disrupted legacies of fragmented governance and financing to create priority for childhood cancer care. In India, the role of a uniquely empowered private actor was instrumental in creating political priority and establishing sustained channels of financing for childhood cancer care. In the Philippines, the childhood cancer community has capitalized on a window of opportunity to expand access and reduce disparities in childhood cancer care through the political prioritization of UHC and NCDs in current health system reforms.

conclusionsThe importance of key health system actors in determining the relative political priority for childhood cancer in the countries studied points to actor power as a critical enabler of prioritization in other LMIC. Responsiveness to political contexts-in particular, rhetorical and policy priority placed on NCDs and UHC-will be crucial to efforts to place childhood cancer firmly on national health agendas. National governments must be convinced of the potential for foundational health system strengthening through attention to childhood cancer care, and the presence and capability of networked actors primed to amplify public sector investments and catalyze change on the ground.

Indexed as

Health PolicyHealth PrioritiesPoliticsAdolescentChildChild, PreschoolDeveloping CountriesEl SalvadorGhanaGovernment ProgramsGuatemalaHealthcare DisparitiesHealth Services Needs and DemandHumansIndiaInfant

Identifiers

PMID31425526
PMCPMC6699697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.